APA (7th ed.) Citation

Y, X., H, S., D, S., & C, Z. (2026). Pharmacological strategies to overcome immune checkpoint inhibitor resistance in non-small cell lung cancer. Frontiers in oncology, 15, 1665239. https://doi.org/10.3389/fonc.2025.1665239

Chicago Style (17th ed.) Citation

Y, Xu, Shen H, Shang D, and Zhu C. "Pharmacological Strategies to Overcome Immune Checkpoint Inhibitor Resistance in Non-small Cell Lung Cancer." Frontiers in Oncology 15 (2026): 1665239. https://doi.org/10.3389/fonc.2025.1665239.

MLA (9th ed.) Citation

Y, Xu, et al. "Pharmacological Strategies to Overcome Immune Checkpoint Inhibitor Resistance in Non-small Cell Lung Cancer." Frontiers in Oncology, vol. 15, 2026, p. 1665239, https://doi.org/10.3389/fonc.2025.1665239.